Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
3(27%)
Results Posted
50%(1 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
8
73%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(2)
Terminated(3)
Other(3)

Detailed Status

Recruiting3
unknown3
Terminated2
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (20.0%)
N/A8 (80.0%)

Trials by Status

recruiting327%
terminated218%
unknown327%
withdrawn19%
completed218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11